Methoxy Polyethylene Glycol Epoetin Beta

Indications & Dose:

Anaemia associated with renal failure in dialysis or pre-dialysis patients AND not currently treated with erythropoietins

• BY SUBCUTANIOUS OR IV

Above 18 years by SC ir IV initially 600nanograms /kg once every two weeks, adjusted according to response at intervals of at least 4 weeks, maintainance dose of double the previous fortnightly every 4 qwwks.

Symptometic anemia associated with chronic kidney disease in patients who are not on dialysis, not currently treated with erythropoietins,.

• BY SUBCUTANIOUS

Above 18 years by SC initially 1.2 mcg /kg once every four weeks,

Symptometic anemia associated with chronic kidney disease in patients who currently treated with erythropoietins.

• BY SUBCUTANIOUS OR IV

Above 18 years by SC ir IV consult with product literature

Contraindications:

Same as Epotein

Side Effects:

Same as Epotein 

Cautions:

Precautions:

Same as Epotein 

Interaction:

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: